BioVaria Startup Awards go to iRASP Therapeutics and OrganoTherapeutics
New platform for developing therapeutic antibodies against cancer and new approach to the development of drugs for Parkinson’s disease
04-May-2021 -
This year’s virtual BioVaria from 26 to 28 April brought together 250 life-science innovators to hear about the most exciting technologies and start-ups to emerge from publicly funded European research, and to initiate partnerships between science and business. With 75 licensable projects and 16 ...
cancer
drug development
Parkinson's disease
+2